Additionally, since increases in Sirt5 occurred when cancer cells were prevented from undergoing glutaminolysis, we tested whether increases in Sirt5 expression accompanying these stresses could be suppressed by supplementation with DM-αKG and found that to be the case (Fig. 5E). The gene discussed is SIRT5; the disease is cancer.